T1	Pharmacological_substance 36 45	sorafenib
N1000 	Reference T1 MeSH:C471405	sorafenib
T2	Pharmacological_substance 50 62	prednisolone
N1001 	Reference T2 MeSH:D011239	prednisolone
T3	Disorder 81 105	hepatocellular carcinoma
N1 	Reference T3 UMLS:C2239176	hepatocellular carcinoma
T4	Pharmacological_substance 107 116	Sorafenib
N1002 	Reference T4 MeSH:C471405	Sorafenib
T8	Pharmacological_substance 300 309	sorafenib
N1003 	Reference T8 MeSH:C471405	sorafenib
T9	Pharmacological_substance 365 374	sorafenib
N1004 	Reference T9 MeSH:C471405	sorafenib
T13	Pharmacological_substance 398 410	prednisolone
N1005 	Reference T13 MeSH:D011239	prednisolone
T14	Disorder 429 453	hepatocellular carcinoma
N2 	Reference T14 UMLS:C2239176	hepatocellular carcinoma
T15	Disorder 455 458	HCC
N3 	Reference T15 UMLS:C2239176	HCC
T16	Disorder 512 515	HCC
N4 	Reference T16 UMLS:C2239176	HCC
T17	Pharmacological_substance 538 547	sorafenib
N1006 	Reference T17 MeSH:C471405	sorafenib
T19	Pharmacological_substance 575 584	sorafenib
N1007 	Reference T19 MeSH:C471405	sorafenib
T20	Disorder 609 622	drug eruption
N5 	Reference T20 UMLS:C0011609	drug eruption
T21	Pharmacological_substance 669 678	sorafenib
N1008 	Reference T21 MeSH:C471405	sorafenib
T23	Pharmacological_substance 718 730	prednisolone
N1009 	Reference T23 MeSH:D011239	prednisolone
T24	Pharmacological_substance 732 744	Prednisolone
N1010 	Reference T24 MeSH:D011239	Prednisolone
T27	Pharmacological_substance 847 856	sorafenib
N1011 	Reference T27 MeSH:C471405	sorafenib
T28	Pharmacological_substance 908 917	sorafenib
N1012 	Reference T28 MeSH:C471405	sorafenib
T29	Pharmacological_substance 964 976	prednisolone
N1013 	Reference T29 MeSH:D011239	prednisolone
T30	Disorder 1024 1038	oral mucositis
N6 	Reference T30 UMLS:C0038362	oral mucositis
T31	Pharmacological_substance 1085 1094	sorafenib
N1014 	Reference T31 MeSH:C471405	sorafenib
T33	Pharmacological_substance 1158 1167	sorafenib
N1015 	Reference T33 MeSH:C471405	sorafenib
T35	Disorder 1212 1226	oral mucositis
N7 	Reference T35 UMLS:C0038362	oral mucositis
T36	Pharmacological_substance 1276 1285	sorafenib
N1016 	Reference T36 MeSH:C471405	sorafenib
T40	Disorder 1456 1467	liver tumor
N8 	Reference T40 UMLS:C0023903	liver tumor
T41	Pharmacological_substance 1553 1565	prednisolone
N1017 	Reference T41 MeSH:D011239	prednisolone
T42	Pharmacological_substance 1581 1590	sorafenib
N1018 	Reference T42 MeSH:C471405	sorafenib
T43	Pharmacological_substance 1662 1671	sorafenib
N1019 	Reference T43 MeSH:C471405	sorafenib
T5	Subject 66 75	a patient
T12	Subject 414 423	a patient
T45	Subject 477 496	a 72-year-old woman
T46	Pharmacological_substance 861 885	its major metabolite M-2
T47	Pharmacological_substance 1099 1102	M-2
T48	Pharmacological_substance 1290 1293	M-2
T34	Disorder 1502 1506	rash
N9 	Reference T34 UMLS:C0015230	rash
T51	Pharmacological_substance 383 397	CYP3A4 inducer
N1020 	Reference T51 MeSH:D065701	CYP3A4 inducer
N1021 	Reference T51 MeSH:D065701	CYP3A4 inducer
T11	Coreferring_mention 517 520	She
T53	Coreferring_mention 643 646	she
T55	Combination 695 707	concurrently
